Back to 
Millennium Management LLC
Millennium Management LLC
XLO
Showing 4 of 13 quarters
Position history for Millennium Management LLC's holdings in Xilio Therapeutics, Inc.
No. Millennium Management exited its XLO (Xilio Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 51,110 shares worth $37,024. Millennium Management first reported XLO in Q2 2022 and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$16,270
Total Shares Change
-20,655
Quarter-by-Quarter History